Carlsbad new corporate hub for cannabis product firm Sunniva


Work is underway on a new Sunniva cannabis production facility Cathedral City, shown in this photo. Sunniva is moving corporate operations to Carlsbad from Canada. (Sunniva photo)

North Coast Current

Carlsbad is set to become a new corporate location for Sunniva, a developer of cannabis products in Canada and California, the company announced May 31.

The move from Vancouver to Carlsbad comes as the company sharpens focus on its California operations, Sunniva stated in a news release. The relocation coincides with the naming of a new California-based chief financial officer.

David Lyle, former CFO of energy storage and power delivery company Maxwell Technologies Inc., joins Sunniva as CFO starting June 3. Lyle replaces David Negus, who shifts to a consultant role this month, the company reported.

“David Negus’ guidance and leadership has been instrumental in creating the financial systems and infrastructure for our Company as we have evolved into a fully operational entity in the U.S.,” Sunniva Chairman and CEO Dr. Anthony Holler said in the announcement. “We are pleased that David will continue to provide his experience to Sunniva throughout this transition period, and we wish him all the best in his future endeavors.”

Sunniva’s move to Carlsbad comes amid the firm’s production of its brands for the California market, according to the company. Medical marijuana has been legal in California since 1996 and is one of several states to expand legalized recreational marijuana in the past several years.

Sunniva develops products under three brandnames, according to its website — Sun Fire, Kyndness and Herbella. In Canada, Sunniva subsidiary Natural Health Services Ltd. operates medical cannabis clinics.

“We are very excited to have someone of David Lyle’s caliber and experience join our executive team and help to continue to move us toward the next phase of Sunniva’s growth,” Holler said in Sunniva’s news release. “We continue to focus our efforts on the completion of our world-class glasshouse in Cathedral City later this year and the development of our marketing and sales infrastructure to support our growth in California.”

Holler is the former CEO and cofounder of ID Biomedical, which was purchased by GlaxoSmithKline in 2005, according to Sunniva’s profile about Holler.

encinitas current, cardiff current, carlsbad current